Prevention of cardiovascular adverse events by clopidogrel in coronary intervention

Abstract

investigate the clinical effect of clopidogrel in the prevention of cardiovascular adverse events in interventional therapy of coronary heart disease . method Select my house 2015 year 9 Month ~2017 year 8 Monthly treatment of coronary heart disease in patients with a total of Example as the object of this study , According to the patient's visit time divide it equally into control groups and observation groups , each group each patients , control group patients underwent routine cardiology treatment , "" , Observation Group to take Clopidogrel and a "" Forest , for preventive treatment , The patient's cardiovascular indicators should be tracked , Understanding Clinical effects . Results Significant differences in coagulation observation results (P <

0.05 , take medicine 6H Post-observation group B 2 The level is significantly lower than the control group , Postoperative 6 the incidence of cardiovascular adverse events in the month observation group is lower than the control Group , difference significant (P<0.05), statistically significant . Conclusion The use of Clopidogrel does not adversely affect the treatment of patients with coronary heart disease. , do not cause condensation Blood dysfunction , for improving platelet aggregation Important effects of,, lowering postoperative cardiovascular events, etc. , has clinical extension value .